NCT00840203View on ClinicalTrials.gov

Mesalamine 4 gm/60 mL Rectal Enema

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

June 30, 2003

Study Completion Date

June 30, 2003

Conditions
Healthy
Interventions
DRUG

Rowasa® 4 gm/60 mL Rectal Enema

1 x 4 gm/60 mL, single-dose

DRUG

Mesalamine 4 gm/60 mL Rectal Enema

1 x 4 gm/60 mL, single-dose

Trial Locations (1)

15206

Novum Pharmaceutical Research Services, Pittsburgh

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00840203 - Mesalamine 4 gm/60 mL Rectal Enema | Biotech Hunter | Biotech Hunter